A 42-year-old man presents with sudden-onset severe headache and neck stiffness. Non-contrast CT head is normal. Lumbar puncture shows xanthochromia. Which imaging modality is most sensitive for detecting the source of bleeding in suspected subarachnoid hemorrhage when CT angiography is inconclusive?

Explanation

## Imaging in Subarachnoid Hemorrhage (SAH) ### Clinical Context This patient has clinical and CSF evidence of SAH (xanthochromia on LP) but a normal CT head. While CT is highly sensitive for acute SAH (>95% within 6 hours), sensitivity decreases over time as blood is metabolized. The question asks for the **most sensitive modality to detect the source** (aneurysm, AVM, or other vascular lesion). ### Comparison of Modalities | Modality | Sensitivity for Aneurysm | Timing | Invasiveness | Role in SAH | |----------|--------------------------|--------|--------------|-------------| | **CT angiography (CTA)** | 95–98% | Acute phase | Non-invasive | First-line when CT+ | | **MRA** | 85–90% | Any time | Non-invasive | Alternative when CTA contraindicated | | **Digital subtraction angiography (DSA)** | 98–100% | Any time | Invasive (catheter) | Gold standard; therapeutic capability | | **Transcranial Doppler** | 60–70% | Any time | Non-invasive | Detects vasospasm, not source | | **Repeat CT** | Same as initial | Delayed | Non-invasive | Not for source detection | ### Why DSA is the Answer **Key Point:** Digital subtraction angiography (DSA) is the **gold standard** and **most sensitive** imaging modality for detecting the source of SAH, with sensitivity approaching 100% for aneurysms ≥3 mm. - **Superior resolution**: Real-time vascular imaging with spatial resolution superior to CTA and MRA. - **Therapeutic capability**: If an aneurysm is identified, coil embolization can be performed in the same session. - **Detects small lesions**: Can identify aneurysms <3 mm that might be missed on CTA/MRA. - **Definitive diagnosis**: When CTA/MRA are inconclusive (as stated in the stem), DSA is the next step. ### Clinical Approach ```mermaid flowchart TD A[Suspected SAH: headache + neck stiffness]:::outcome --> B[Non-contrast CT head]:::action B --> C{CT positive for blood?}:::decision C -->|Yes| D[CTA brain]:::action C -->|No| E[Lumbar puncture]:::action E --> F{Xanthochromia present?}:::decision F -->|Yes| G[Confirmed SAH]:::outcome G --> H{CTA conclusive?}:::decision H -->|Yes| I[Coil embolization if aneurysm]:::action H -->|No| J[DSA - gold standard]:::action J --> K[Identify source + treat]:::action ``` **High-Yield:** In patients with SAH and **inconclusive CTA**, DSA is mandatory before discharge. It is both diagnostic and therapeutic. **Clinical Pearl:** DSA carries a small risk of stroke (~0.5–1%), but this is justified when the source must be identified and treated. MRA is a reasonable non-invasive alternative if DSA is contraindicated (e.g., renal failure, contrast allergy), but it is less sensitive. ### Why Each Distractor is Wrong **Option 0 (MRA):** While MRA is non-invasive and can detect most aneurysms (85–90% sensitivity), it is **less sensitive than DSA** and lacks therapeutic capability. It is a reasonable alternative when DSA is contraindicated, but DSA is more sensitive. **Option 2 (Transcranial Doppler):** TCD detects **vasospasm** (increased flow velocity in narrowed vessels), not the source of bleeding. It is used for surveillance after SAH, not for aneurysm detection. **Option 3 (Repeat CT after 24 hours):** Repeating non-contrast CT does not improve sensitivity for detecting the **source** of bleeding; it merely confirms the presence of blood. It does not identify the aneurysm or vascular lesion responsible. ## Summary **Key Point:** DSA is the **gold standard** for detecting the source of SAH when CTA is inconclusive, with 98–100% sensitivity and the added advantage of allowing immediate therapeutic intervention (coil embolization).